Genome-wide cDNA microarray screening of genes related to the benefits of paclitaxel and irinotecan chemotherapy in patients with advanced non-small cell lung cancer

Journal of Experimental Therapeutics and Oncology

Volumn 6, Issue 1, 2006, Pages 49-53

  Oshita, Fumihiro ^a   Sekiyama, Akiko ^a   Saito, Haruhiro ^a   Yamada, Kouzo ^a   Noda, Kazumasa ^a   Miyagi, Yohei ^a  

^a KANAGAWA CANCER CENTER   (Japan)

Author keywords

Gene; Irinotecan; Lung cancer; Microarray; Paclitaxel

Indexed keywords

COMPLEMENTARY DNA; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; INTERLEUKIN 1ALPHA; IRINOTECAN; PACLITAXEL; PHOSPHOPROTEIN PHOSPHATASE; PROTIRELIN RECEPTOR; RANITIDINE;

ADULT; AGED; ALKYLATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA MICROARRAY; DRUG EFFICACY; FEMALE; GENE EXPRESSION REGULATION; GENETIC SCREENING; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL TIME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME; HUMANS; INTERLEUKIN-1ALPHA; LUNG NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; RECEPTORS, THYROTROPIN-RELEASING HORMONE;

EID: 33846094033     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Miya T, Okamoto H, Iemura K, Saijo N. A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy. Cancer Chemother Pharmacol 30:1-6, 1992.
2. Oshita F, Ikehara M, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda Y, Miyagi Y. Genome-wide cDNA microarray screening of genes related to benefits and toxicities of platinum-based chemotherapy in patients with advanced lung cancer. Am J Clin Oncol 28:367-370, 2005.
3. Yamada K, Ikehara M, Tanaka G, Nomura I, Oshita F, Noda K. Dose escalation study of paclitaxel in combination with fixed dose irinotecan in patients with advanced non-small cell lung cancer (JCOG9807). Oncology 66:94-100, 2004.
4. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabheke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92:205-216, 2000.
5. Liao Y, Hung MC. A new role of protein phosphatase 2a in adenoviral EI A protein-mediated sensitixation to anticaneer drug-induced apoptosis in human breast cancer cells. Cancer Res 64:5938-5942, 2004.
6. Jia SF, Zwelling LA, McWatters A. An T and Kleinerman ES. Interleukin-1 alpha increases the cytotoxic activity of etoposide against human osteosarcoma cells. J Exp Ther Oncol 2:27-36, 2002.
7. Mazzoccoli G, Carughi S, De Cata A, La Viola M, Giuliani A, Tarquini R, Perfetto F. Neuroendocrine alterations in lung cancer patients. Neuro Endocrinol Lett 24:77-82, 2003.
8. Luo LG, Yano N. Expression of thyrotropin-releasing hormone receptor in immortalized beta-cell lines and rat pancreas. J Endocrinol 181:401-412, 2004.
9. Gifford G, Paul J, Vasey PA, Kaye SB, Brown R. The acquisition of hMLHI methylation in plasma DNA aller chemotherapy predicts poor survival for ovarian cancer patients. Clin Cancer Res 10:4420-4426, 2004.